Biotechnology Focus

Laboratory Focus September 2011

Biotechnology Focus is Canada's leading authority on Canada's life science news. From biopharma and healthcare to ag-bio and clean tech, our readership includes life science professionals, C-level executives and researchers.

Issue link:

Contents of this Issue


Page 0 of 19

PHARMACEUTIC AL CLINIC AL CHEMIC AL FOOD ENVIRONMENT Perfect Homogenization of Food Samples Page 10 Automation in the Pharmaceutical SEPTEMBER 2011 Volume 15, Number 5 Trends in Laboratory & Biotechnology Industry Sector Page 12 R&D News ......................... 1 Appointments .................... 6 Pharma Notes .................... 7 New Products ..................15 Calendar ..........................17 Career Spotlight...............18 CERVICAL CANCER SCREENING LAB RECEIVES CAP ACCREDITATION The British Columbia Provincial Health Services Authority (PHSA) announces that its Cervical Cancer Screening Lab (CCSL) at the BC Cancer Agency has been granted full accreditation status by the College of American Pathologists (CAP). This is the first time CAP has accredited an anatomic pathology laboratory in BC. CCSL, a division of PHSA Labora- tories, provides gynecological cytol- ogy interpretations. It implemented the world's first organized cervical cancer screening program. Associ- ated with the provincial Cervical Cancer Screening Program at the BC Cancer Agency, an agency of the PHSA, this laboratory performs the Pap screening for the entire province, with cytotechnologists screening approximately 600,000 smears annually. The lab also tests for Human Papillomavirus (HPV) as needed. Cytotechnologist examines Pap slide in Cervical Cancer Screening Laboratory (CCSL). Photo: Cameron Heryet, BC Cancer Agency. CAP is the world's largest as- sociation composed exclusively of pathologists certified by the American Board of Pathology and is widely considered the leader in laboratory quality assurance. The goal of the CAP Laboratory Accredi- tation Program is to improve patient safety by advancing the quality of pathology and laboratory services through education, standard setting and ensuring laboratories meet or exceed regulatory requirements. Upon successful completion of the inspection process, the laboratory is awarded CAP accreditation and becomes part of a select group of more than 7,000 laboratories worldwide that have met the high- est standards of excellence. "The CAP accreditation standard is regarded as one of the most stringent standards for laboratory accreditation," says Dr. Dirk van Niekerk, Medical director, CCSL and Medical leader, Cervical Can- cer Screening Program. "The CAP Program assures that a laboratory meets the highest standards of ex- cellence by producing high quality test results that positively impact patient care. This achievement has an additional honor for the Cervi- cal Cancer Screening Lab in that it is the first anatomic pathology laboratory in BC to achieve CAP accreditation." EDMONTON BECOMES NORTH AMERICAN MICROSCOPE LEADER Thanks to an international col- laboration, Canadian companies will now have access to a uniquely configured transmission electron microscope, the first of Publications Mail Registration Number: 40052410 its kind outside of Japan. It is one of three new microscopes that were unveiled at the official opening of the Hitachi Electron Microscopy Products Centre (HEMiC) at the Na- tional Institute for Nanotechnology Continued on page 3

Articles in this issue

Links on this page

view archives of Biotechnology Focus - Laboratory Focus September 2011